Nexalis Therapeutics LimitedASX: NX1

IRX-616a Study Order Executed to Commence Phase 1

Apr 17, 2025 at 4:08 AM UTC · Issued by Nexalis Therapeutics Limited

Nexalis Therapeutics Limited has released a press release.

View Attachment